Efficacy of vaccines against bacterial diseases in swine: what can we expect?
about
Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East?Safety and Immunogenicity of a Mycoplasma ovipneumoniae bacterin for domestic sheep (Ovis aries)The commercial impact of pig Salmonella spp. infections in border-free markets during an economic recessionCurrent Status of Veterinary VaccinesMicroarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.An experimental model to evaluate Mycoplasma hyopneumoniae transmission from asymptomatic carriers to unvaccinated and vaccinated sentinel pigs.A clinical field trial to evaluate the efficacy of vaccination in controlling Salmonella infection and the association of Salmonella-shedding and weight gain in pigs.Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaningVaccination reduces macrophage infiltration in bronchus-associated lymphoid tissue in pigs infected with a highly virulent Mycoplasma hyopneumoniae strain.Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.Lactobacillus zeae protects Caenorhabditis elegans from enterotoxigenic Escherichia coli-caused death by inhibiting enterotoxin gene expression of the pathogen.Mycoplasma gallisepticum inactivated by targeting the hydrophobic domain of the membrane preserves surface lipoproteins and induces a strong immune response.A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infectionType IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia.Sequence TTKF ↓ QE defines the site of proteolytic cleavage in Mhp683 protein, a novel glycosaminoglycan and cilium adhesin of Mycoplasma hyopneumoniaeImmune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.A vaccine candidate for post-weaning diarrhea in swine constructed with a live attenuated Salmonella delivering Escherichia coli K88ab, K88ac, FedA, and FedF fimbrial antigens and its immune responses in a murine modelImmunization with recombinant Sao protein confers protection against Streptococcus suis infection.MLVA typing of Mycoplasma hyopneumoniae bacterins and field strainsMonoclonal antibodies against Actinobacillus pleuropneumoniae TonB2 protein expressed in Escherichia coli.Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine modelDraft genome sequence of Actinobacillus pleuropneumoniae serotype 7 strain S-8.Immunological study of an attenuated Salmonella Typhimurium expressing ApxIA, ApxIIA, ApxIIIA and OmpA of Actinobacillus pleuropneumoniae in a mouse modelPassive transfer of maternal Mycoplasma hyopneumoniae-specific cellular immunity to piglets.Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model.Approaches for reducing Salmonella in pork production.Pasteurella multocida: from zoonosis to cellular microbiologyProtective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis.Salmonella Typhimurium lacking the Znuabc transporter is attenuated and immunogenic in pigsSpecific humoral immune response induced by propionibacterium acnes can prevent Actinobacillus pleuropneumoniae infection in miceIn vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models.Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine.Streptococcus suis vaccines: candidate antigens and progress.Microneedles for vaccine delivery: challenges and future perspectives.Salmonella Vaccination in Pigs: A Review.Characterization of cleavage events in the multifunctional cilium adhesin Mhp684 (P146) reveals a mechanism by which Mycoplasma hyopneumoniae regulates surface topography.A processed multidomain mycoplasma hyopneumoniae adhesin binds fibronectin, plasminogen, and swine respiratory cilia.Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.
P2860
Q21092386-5184D839-3BE3-4B45-B7E5-998857D9BE0EQ21132051-6A315508-3931-4961-A366-58F12D78C4E8Q26752440-2843376F-75CB-4801-AD8B-92912FB4C34AQ27480923-4DBAC023-EE43-413E-91AC-1393793A59ABQ33411995-640928AA-8663-4527-BE72-C6B6FC0A849EQ33569921-BF6307F9-D23F-4958-BAB0-57C2BAC49A74Q33777549-614A771D-DDA8-460E-8DFD-A60F21E05097Q34171776-5A5AD58B-0469-4133-83C2-DF21ACBD510BQ34190017-0A496CDD-C506-4998-9806-F7FA7A269FD4Q34191863-C8C992AF-5807-4E89-948F-04DEE81C09FDQ34222608-15EE1A9D-DB80-4E7B-B216-3BCE06E98103Q35099764-F31AB745-8753-4BCC-9B79-240659908363Q35186562-B4CA2E77-153D-42AA-AE1C-9B32A0C2F416Q35271028-0883ACE9-F3A0-4701-B525-3D0FCFB25D24Q35747681-1C640475-6FCD-471F-900B-8BF305AF22C3Q35842081-950BA076-0B60-438B-8C31-3D72B3ED3702Q35946937-0C63DE58-2AB7-4A7C-8AFE-8AA312F86A35Q36061825-307B6562-DF32-4B45-B701-8443AB384AEFQ36097153-9D20142F-4CDF-4089-8D5B-94CABE552E44Q36162906-B0207EFA-7E33-4CBB-9FFF-78B800AA70E5Q36351038-AD4E4882-A7A8-48C5-AFA4-D8A80199E3EDQ36390119-9C5CF1A9-0306-4680-976E-284411562DD4Q36397069-78DDC4A1-2C62-4DC8-BF1D-153B2E9B7647Q36456566-4960A888-043D-4E72-86FB-57F83185B4CFQ36497670-54A5E17C-FF89-4B8E-A908-49E02E98862BQ36523714-3A05AAC3-66D5-4941-8E5E-062435E26D35Q37017500-7B055CDE-F2A8-4CC4-936C-CCD118F25EE2Q37035816-B6ACB483-8CB7-4439-8F5F-B3F4E9CBEA7CQ37046073-07D8728F-4057-46F3-B7C9-BB88B3E3C81BQ37418740-6BC61798-84EA-4FC6-88E3-840E7E546EDEQ37643330-A338322B-1804-4B6A-A587-015E41397A70Q37653394-DFA7288D-200A-4437-8F62-4A5138A971DAQ37764973-9E979EA2-990F-4C79-9C9F-4B9909598EE1Q38211771-1B6D06C4-5C8B-4BC5-A0F6-6A9EA2782108Q38607624-D8F555E5-2867-4CF6-AD34-8FA70C520AECQ38681048-B34B6429-6D73-4B16-B5C9-96468F287555Q38725470-3151E66F-1355-4602-A506-030DF86E4096Q39366298-AFB3BB5F-E5E3-4220-A67E-CD0A849BFDC8Q39660110-28734A0B-AE85-4E7D-84DB-6CF7DC3BB83AQ40015954-EBE2C7B2-CE61-41FC-AD47-3EBB1FC9E149
P2860
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@ast
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@en
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@nl
type
label
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@ast
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@en
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@nl
prefLabel
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@ast
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@en
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@nl
P2093
P50
P1476
Efficacy of vaccines against bacterial diseases in swine: what can we expect?
@en
P2093
Annemie Decostere
Dominiek Maes
Koen Chiers
P304
P356
10.1016/J.VETMIC.2004.03.002
P577
2004-06-01T00:00:00Z